Oral hyaluronic acid: what it can offer and what not to expect

By age 40, your body produces roughly half the hyaluronic acid it produced at 20. The decline does not stop there. And the consequences — stiffer joints, less hydrated skin, tissues that lose elasticity — are no accident: they are biochemistry.

Oral hyaluronic acid has occupied pharmacy shelves and health-magazine headlines for years. But between the enthusiasm of marketing and the scepticism of those who recall that 'whatever you eat gets digested', the real question is more nuanced: what does science say about its bioavailability and its effects when taken orally?

The short answer: the evidence exists, is growing and is promising in specific areas — joints, skin hydration, intestinal integrity. But it also has clear limits worth knowing before spending on a supplement. This article gathers the most relevant clinical studies published up to 2025, explains the mechanism by which ingested hyaluronic acid may act beyond the digestive tract, and honestly defines what cannot be expected from it.

Informative note: This article is for informational and educational purposes. It does not replace professional medical advice. Consult your doctor or pharmacist before starting any supplementation, especially if you have diagnosed health conditions or take chronic medication.

Health claims: EFSA has not authorized specific health claims for oral hyaluronic acid. The benefits described in this article are based on a review of published scientific studies.

If you are looking for a reference source that analyzes the available evidence without simplifying or exaggerating it, this article is written for you.

What hyaluronic acid is and why it matters in longevity

Hyaluronic acid (HA) is a glycosaminoglycan — a long chain of sugars — present naturally in practically all tissues of the human body. Its main function is to retain water: a single HA molecule can capture up to 1,000 times its weight in water, making it the main contributor to the viscosity of synovial fluid, dermal hydration and the elasticity of connective tissue.

The adult body contains approximately 15 grams of hyaluronic acid, distributed mainly in the skin (50%), the joints, the eyes and connective tissue. It is estimated that at age 40 we produce roughly half the HA we produced at 20, and the decline continues with age (Papakonstantinou et al., 2012). This progressive decline is associated with loss of skin elasticity, increased joint stiffness and reduced ocular lubrication.

From the perspective of cellular longevity, HA is not merely a passive lubricant. Recent research shows that low-molecular-weight HA fragments act as tissue-damage signals (DAMPs) that modulate the inflammatory response, while high-molecular-weight HA has anti-inflammatory and extracellular-matrix-protective properties (Jiang et al., 2011). This duality makes the molecular weight of HA in a supplement a relevant technical factor, not a minor label detail.

Molecular weight: the detail that changes everything

HA is marketed in two broad molecular-weight ranges:

• High molecular weight (> 1,000 kDa): greater water-retention capacity, anti-inflammatory effect in joint tissue, but lower intestinal absorption.
• Low molecular weight (< 50 kDa, especially 5-10 kDa): better oral bioavailability demonstrated in pharmacokinetic studies, greater ability to cross the intestinal barrier and reach target tissues.

A third, emerging format is HA oligosaccharides (< 10 kDa), which show the highest bioavailability in animal models and the first human studies (Asari et al., 2010).

When you evaluate an oral HA supplement, the molecular weight is not always shown on the label. It is one of the questions worth asking the manufacturer.

Is hyaluronic acid taken orally absorbed? The question of bioavailability

For years, the most widespread objection to oral HA was simple: digestive enzymes degrade it before it can be absorbed. This objection has a real basis. But research over the past decade has considerably nuanced the picture.

What really happens in the digestive tract

When you ingest HA, intestinal hyaluronidase and microbiome bacteria break it down into low-molecular-weight oligosaccharides. For a long time these fragments were assumed to be metabolically irrelevant. Pharmacokinetic studies tell a different story:

1. Low-molecular-weight HA fragments (< 10 kDa) are absorbed in the small intestine and are detected in plasma between 30 minutes and 4 hours after ingestion.
2. Part of the ingested HA reaches the colon intact, where it can serve as a substrate for beneficial bacteria, with potential effects on the microbiota.
3. The absorbed fragments are redistributed toward tissues with a high concentration of CD44 receptors — the main HA receptor — including the skin, cartilage and synovial membrane.

Evidence in animal models and in humans

A pharmacokinetic study by Balogh et al. (2008) administered carbon-14-labelled HA to rats and dogs and tracked its distribution. The results showed detectable intestinal absorption and accumulation in joint and skin tissue at 48 hours, with an estimated bioavailability of 10-20% of the ingested dose. Although this is an animal model, these tissue-distribution data are consistent with the clinical effects later observed in human trials.

A clinical trial by Kawada et al. (2014), with a double-blind placebo-controlled design, confirmed that oral supplementation with low-molecular-weight HA (200 mg/day for 12 weeks) significantly increased plasma HA levels and was associated with improvements in skin-hydration parameters (p < 0.05). The sample size and exact molecular weight of the HA used should be consulted in the original article for a precise interpretation of the results.

The honest conclusion on bioavailability

Oral HA is not absorbed with the efficiency of an injectable drug. But the premise that 'it is completely destroyed in digestion' is superseded by the evidence. Absorption exists, it is partial, and the absorbed fragments are biologically active. The magnitude of the effect depends on the molecular weight of the HA, the dose and the duration of supplementation.

Benefits of oral hyaluronic acid supported by clinical evidence

Human clinical studies on oral HA concentrate on three main areas: joint health, skin hydration and elasticity, and integrity of the intestinal mucosa. What follows is an honest analysis of the available evidence in each.

Joint health: the area with the most evidence

Osteoarthritis is the indication with the most published clinical studies on oral HA. The proposed mechanism is twofold: on one hand, the absorbed HA fragments appear to stimulate synoviocytes (synovial membrane cells) to produce more endogenous HA; on the other, in vitro studies and animal models further suggest a modulation of the local inflammatory response through the reduction of pro-inflammatory cytokines such as IL-1β and TNF-α (Jiang et al., 2011), although direct translation of these mechanisms to oral supplementation in humans requires further clinical research.

A randomized, double-blind, multicentre clinical trial by Tashiro et al. (2012) showed that oral supplementation with HA was associated with reduced joint pain versus placebo in participants with knee osteoarthritis. A randomized clinical trial by Kalman et al. (2008), with 80 participants with chronic joint pain, showed that 80 mg/day of low-molecular-weight HA for 8 weeks significantly reduced pain during activities of daily living (p < 0.05) versus placebo.

What the evidence does NOT say about joints: oral HA does not regenerate damaged cartilage. The studies show symptom reduction and functional improvement, not reversal of joint degeneration. This is an important nuance for managing expectations.

Skin hydration and elasticity

The skin is the tissue with the highest concentration of HA in the body and, therefore, one of those that benefits most from supplementation. Several clinical trials of moderate-to-high quality show positive effects on objective parameters of skin hydration.

A double-blind trial by Göllner et al. (2017), with 45 women aged 45-60, evaluated the effect of 120 mg/day of oral HA over 12 weeks. The results showed a 28% increase in skin hydration measured by corneometry (p < 0.01) and a 10% reduction in wrinkle depth measured by image analysis (p < 0.05) versus placebo.

A systematic review by Michelotti et al. (2021), which analyzed 11 clinical trials on oral supplements for the skin (including 4 specific to HA), concluded that the evidence is consistent in showing improvements in skin hydration, with a favourable safety profile. The methodological quality of the studies was variable, with some limited by small sample sizes.

What the evidence does NOT say about skin: oral HA is not equivalent to injectable dermal fillers. The effects on wrinkles are modest and gradual, not immediate or comparable to invasive aesthetic procedures.

Integrity of the intestinal mucosa

This is the area with the fewest human studies, although the biological mechanisms are well established. HA is a natural component of the gastrointestinal mucosa and plays a role in the repair of the intestinal epithelium. In vitro studies show that HA stimulates the proliferation of intestinal epithelial cells and reduces paracellular permeability (Kogan et al., 2010).

A pilot study by Asari et al. (2010) in patients with irritable bowel syndrome showed improvements in digestive symptoms after 4 weeks of supplementation with oral HA (200 mg/day), although the sample size (n = 20) limits the generalization of the results.

The area is promising but requires further research in humans before solid claims can be made.

How it works: the mechanism of action of oral hyaluronic acid

Understanding why oral HA may work requires going beyond the simplistic idea of 'you take HA → it goes to your joints'. The mechanism is more indirect and, in a way, more interesting.

Mechanism 1: Stimulation of endogenous synthesis

The absorbed HA fragments act as signals that stimulate HA-producing cells — fibroblasts in the skin, synoviocytes in the joints — to increase their own production. It is a signalling effect, not direct replacement. This explains why the effects are gradual (observed from 4-8 weeks onward) and why the dose matters less than regularity.

Mechanism 2: Interaction with the CD44 receptor

The CD44 receptor is the main HA receptor in immune cells, fibroblasts and epithelial cells. In vitro studies show that low-molecular-weight HA fragments can interact with the CD44 receptor and influence the production of pro-inflammatory cytokines such as IL-1β, TNF-α and IL-6 (Jiang et al., 2011). Researchers have explored whether this mechanism could be relevant in the context of the chronic low-grade inflammation associated with ageing — termed 'inflammaging' — although direct clinical evidence in humans on this specific effect of oral HA is still limited.

Mechanism 3: Prebiotic effect on the microbiome

The HA that is not absorbed in the small intestine reaches the colon, where preliminary studies suggest it may serve as a substrate for beneficial bacteria such as Bifidobacterium and Lactobacillus. In theory, fermentation of these oligosaccharides could produce short-chain fatty acids such as butyrate, with favourable effects on the intestinal barrier. This complete chain, however, has not been demonstrated in human clinical trials and should be considered a plausible hypothetical mechanism, not an established effect.

Mechanism 4: Protection of the extracellular matrix

High-molecular-weight HA acts as a structural scaffold for the extracellular matrix, protecting collagen and elastin fibres from enzymatic degradation. Although this mechanism is more relevant for injected or endogenously produced HA, the stimulation of endogenous synthesis (mechanism 1) contributes indirectly to this protective effect.

What not to expect from oral hyaluronic acid: honest limits of the evidence

Being rigorous with the evidence means being as clear about what oral HA cannot do as about what it can. These are the most important limits.

It is not equivalent to intra-articular injections

HA injections directly into the joint (viscosupplementation) have decades of clinical evidence and act directly on the synovial fluid. Oral HA acts indirectly and its effects are more modest. If you have advanced osteoarthritis with severe pain, oral HA can be a useful complement, but not a substitute for established medical treatments.

It does not regenerate damaged cartilage

No clinical study has demonstrated that oral HA reverses the loss of joint cartilage. The documented benefits concern symptoms (pain, stiffness, function) and inflammatory markers, not the structure of the cartilage. The magnetic resonance imaging from the available studies does not show cartilage regeneration.

It does not erase wrinkles like a dermal filler

The effects on the skin are real but gradual and modest. A 10-28% improvement in skin hydration or a slight reduction in wrinkle depth after 12 weeks is a clinically relevant result, but not comparable to the immediate, pronounced effects of injectable fillers. Anyone expecting dramatic aesthetic results will be disappointed.

The effects are not immediate

Most studies show that the benefits begin to be noticeable between weeks 4 and 8, and reach their maximum between weeks 8 and 12. This is consistent with the mechanism of stimulating endogenous synthesis, which requires time. If you notice nothing in the first two weeks, it does not mean it is not working.

The quality of the supplement matters a great deal

Not all oral HA supplements are equivalent. Differences in molecular weight, purity, dose and pharmaceutical form significantly affect bioavailability and effects. A product with high-molecular-weight HA without gastric-protection technology may have a much lower bioavailability than one formulated with low-molecular-weight HA or with an enteric coating. The lack of specific regulation for supplements in this respect makes the choice of manufacturer relevant.

The evidence in some areas is still limited

The effects on the intestinal mucosa, dry eye and microbiome health are promising but based on pilot studies with small samples. It is not that they do not work — the biological mechanisms are solid — but rather that the clinical evidence in humans is not yet sufficient to make categorical claims.

Dosing, dosage forms and when to take it

Reviewing the available clinical trials allows some guidance to be drawn on dose and format, although it is worth remembering that these are the doses used in the studies, not individualized medical recommendations.

Doses used in clinical studies

Doses above 200 mg/day have not shown greater efficacy in the available studies, although they have not been associated with significant adverse effects either.

How long does oral hyaluronic acid take to work?

Clinical studies show that the first measurable effects — on skin hydration and reduction of joint pain — appear between weeks 4 and 8 of continuous supplementation. Maximum effects are generally observed between weeks 8 and 12. This pace is consistent with the mechanism of stimulating endogenous synthesis, which requires time to translate into measurable tissue changes. Consistency in daily intake is more decisive than the exact dose.

Molecular weight: the most important variable

As explained, low-molecular-weight HA (< 50 kDa, ideally 5-10 kDa) shows greater oral bioavailability. When choosing a supplement, look for the manufacturer to specify the molecular weight of the HA used. If it is not specified, that is a warning sign.

Dosage forms

• Capsules or tablets: the most common form. Allows precise dosing.
• Powder to dissolve: useful for those who have difficulty swallowing capsules, but the stability of HA in aqueous solution is lower.
• Combined formulations: HA is frequently combined with hydrolyzed collagen, vitamin C (necessary for collagen synthesis), glucosamine or chondroitin. These combinations have biological logic, but make it harder to attribute the effects to a single ingredient.

When to take it

The studies do not establish an optimal time of day. Some manufacturers recommend taking it on an empty stomach to minimize competition with other dietary polysaccharides, but this recommendation is not supported by solid clinical evidence. Consistency in daily intake is more important than the exact timing.

Interactions and special considerations

Oral HA has a very favourable safety profile in the available studies. No relevant drug interactions have been described. However, people with an allergy to poultry-derived products (many HA supplements are obtained from rooster combs) should verify the origin of the HA in the product. There are HA formulations of fermentative (biotechnological) origin that avoid this problem.

If you are pregnant, breastfeeding or taking chronic medication, consult your doctor or pharmacist before starting any supplementation.

Safety and side effects of oral hyaluronic acid

Oral hyaluronic acid has one of the most favourable safety profiles among supplements for joints and skin. The available clinical studies, with durations of up to 12 months, have not identified serious adverse effects attributable to its intake.

Adverse effects reported in clinical studies

The most frequent adverse effects, reported in a minority of participants, are mild and transient gastrointestinal in nature:

• Mild digestive discomfort (nausea, feeling of fullness): < 5% of participants in most studies
• Occasional diarrhoea: < 3%
• These effects usually disappear within the first days of supplementation

Relative contraindications

• Allergy to poultry products: HA of animal origin (rooster comb) can provoke reactions in allergic individuals. Choosing HA of fermentative origin eliminates this risk.
• People with active cancer or an oncological history: the CD44 receptor plays a role in the biology of various cell types, including some tumour cells (Toole, 2004). There is no clinical evidence that oral supplementation with HA promotes tumour growth in humans, but given that research in this specific context is limited, consulting the responsible oncologist before starting any supplementation is recommended.
• Pregnancy and breastfeeding: there are no specific safety studies in these situations. As a precaution, it is recommended to avoid supplementation or consult a doctor.

Regulatory position

Hyaluronic acid is approved as a food ingredient in the European Union (Commission Implementing Regulation EU 2023/2419), which permits its use in food supplements. However, EFSA has not approved any specific health claim for oral HA to date. This means that supplements can be marketed legally, but cannot make authorized health claims about their effects.

The absence of an EFSA-approved health claim reflects that the formal scientific evaluation process has not yet been completed for this ingredient via this route of administration, not necessarily that the available evidence is negative. In any case, while no authorized claims exist, no oral HA supplement may make health-benefit claims in its labelling or advertising in the European Union.

The golden rule: if you have any doubt about whether oral HA is appropriate for your specific situation, consult your doctor or pharmacist.

Oral hyaluronic acid and longevity: the integrative-medicine perspective

From the perspective of cellular longevity, oral hyaluronic acid fits within a broader framework of interventions that seek to maintain the functionality of the extracellular matrix and reduce chronic low-grade inflammation — two of the pillars of biological ageing.

'Inflammaging' and the role of HA

The term 'inflammaging', coined by the gerontologist Claudio Franceschi, describes the state of chronic low-grade inflammation that characterizes ageing and underlies many age-related chronic diseases: cardiovascular, metabolic, neurodegenerative and musculoskeletal. HA, through its interaction with the CD44 receptor and the modulation of pro-inflammatory cytokines observed in in vitro studies, may be relevant in this context, although direct clinical evidence in humans on this specific effect of oral HA is still limited (Jiang et al., 2011).

Synergy with other longevity ingredients

Oral HA does not act in a vacuum. In the context of an integral longevity strategy, it shows potential synergies with:

• Hydrolyzed collagen: HA and collagen are the two main components of the extracellular matrix. Their combined supplementation has biological logic and some studies show additive effects on the skin and joints.
• Vitamin C: essential for collagen synthesis and for the activity of the enzymes that produce endogenous HA (hyaluronan synthases).
• NAD+ and its precursors (NR, NMN): NAD+ is a coenzyme present in all cells that participates as a cofactor in more than 500 enzymatic reactions, including those catalyzed by the sirtuins (Yoshino et al., 2021). Research on the interactions between NAD+ metabolism and extracellular-matrix biology is an active area; the precise mechanisms in humans are still being characterized and do not yet allow conclusive claims about synergistic effects with oral HA.
• Antioxidants (vitamin E, resveratrol, astaxanthin): oxidative stress degrades the HA of the extracellular matrix. Antioxidants protect endogenous HA from degradation.

A realistic perspective

Oral HA is a useful complement within a longevity strategy, not a single solution. The most solid studies show modest but consistent benefits in specific areas — joint health, skin hydration, potential modulation of inflammation. In the context of a lifestyle that includes regular exercise, anti-inflammatory nutrition, quality sleep and stress management, oral HA supplementation can be an additional component to consider, especially in people who present the decline in endogenous synthesis associated with ageing.

Frequently asked questions about oral hyaluronic acid

Is oral hyaluronic acid better than topical?

It depends on the goal. Topical HA acts mainly on the skin surface, improving epidermal hydration immediately but without reaching deeper layers. Oral HA acts from within, stimulating endogenous synthesis in the dermis and other tissues. For deep dermal hydration and joint benefits, the oral route is more relevant. For immediate surface hydration, the topical form is more effective. Many specialists recommend combining both routes for a complementary effect.

How long does oral hyaluronic acid take to work?

Clinical studies show that the first measurable effects — on skin hydration and reduction of joint pain — appear between weeks 4 and 8 of continuous supplementation. Maximum effects are generally observed between weeks 8 and 12. This pace is consistent with the mechanism of stimulating endogenous synthesis, which requires time to translate into measurable tissue changes. Consistency in daily intake is more decisive than the exact dose.

Can people with osteoarthritis take it?

The most solid evidence on oral HA has been generated precisely in people with knee osteoarthritis. The randomized, double-blind, multicentre clinical trial by Tashiro et al. (2012) and that of Kalman et al. (2008) showed a significant reduction in pain and functional improvement. However, oral HA does not replace the medical treatment of osteoarthritis. It should be considered a complement, not an alternative to the treatments prescribed by the doctor. Always consult your rheumatologist or general practitioner before starting supplementation if you have a diagnosed joint condition.

Is there a difference between HA of animal origin and biotechnological HA?

Yes. HA of animal origin (usually from rooster combs) can provoke reactions in people with an allergy to poultry products. HA of fermentative origin (produced by bacteria such as Streptococcus equi through controlled fermentation) is chemically identical to that of animal origin, has a very high purity profile and eliminates the risk of poultry allergy. From the standpoint of efficacy, there are no documented differences between the two origins when the molecular weight is equivalent.

Can oral hyaluronic acid be taken together with other supplements?

Oral HA has no known drug interactions with other common supplements. In fact, it shows potential synergies with hydrolyzed collagen, vitamin C and antioxidants. If you take chronic medication, consult your doctor or pharmacist to rule out specific interactions with your treatment.

Oral hyaluronic acid occupies a legitimate place in the scientific evidence, with documented benefits in joint health, skin hydration and, in an emerging way, intestinal integrity. The key is to understand what it can offer — reduction of joint pain, improved dermal hydration, potential modulation of chronic inflammation — and what it cannot do: it does not regenerate cartilage, it is not equivalent to injectable fillers and its effects are gradual, not immediate.

The oral bioavailability of HA, questioned for years, is today supported by pharmacokinetic studies that demonstrate intestinal absorption and redistribution to target tissues. The molecular weight of the HA in the supplement is the most relevant technical factor for bioavailability. It is worth asking the manufacturer about it.

From the perspective of longevity, oral HA fits as a component of an integral strategy that includes exercise, anti-inflammatory nutrition and, potentially, other ingredients with evidence in cellular longevity. It is not a single solution, but neither is it an expensive placebo: the evidence, with its nuances, supports it.